Myriad Genetics Inc (MYGN) · Nov 5, 2026 · Cybersecurity

Myriad Genetics cyberattack disrupts testing while patient-data exposure remains unknown

Cyber incident

Myriad Genetics disclosed a cyberattack that temporarily suspended testing and order systems. Operations are mostly restored, but the patient-data investigation is unfinished.

Myriad is trying to shift its business toward the cancer-care continuum while streamlining operations and selling its prenatal-testing unit to focus capital and attention on that strategy.

The incident temporarily hit core operating systems, not just back-office infrastructure. Myriad said it suspended testing operations and order-management systems while resetting credentials and investigating unauthorized access. 〔0〕

The immediate disruption appears contained, but the important risk is unresolved. Most systems have returned to normal, and management currently believes there will be no material business impact; however, the company has not finished determining whether patient records were accessed. 〔1〕 〔2〕

That makes this a modest setback to execution rather than a rewritten business story. The filing does not disclose a confirmed material loss, prolonged outage, or known patient-data breach, but it adds operational, regulatory, legal, and reputational uncertainty while Myriad is already navigating a strategic transition.

Bottom line: Myriad has restored most systems, but the cyber incident is not fully understood. Until the patient-data and business-impact assessment is complete, it modestly clouds an otherwise active operating transition rather than changing the company’s overall direction.

What to watch next

Forensic investigation and patient-data assessment

Original filing on SEC EDGAR

More Myriad Genetics Inc news

Myriad Genetics cyberattack disrupts testing while patient-data exposure remains unknown | MYGN Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.